Topic

Bladder Cancer

2 claims checked

HEALTH Mar 26, 2026

Anktiva is approved only for BCG-unresponsive non-muscle-invasive bladder cancer.

Claim: Anktiva (nogapendekin alfa inbakicept) is approved and clinically effective for treating, curing, or preventing all types of cancer, not solely bladder cancer. TOTAL BS

HEALTH Mar 25, 2026

N-803 (Anktiva) is in clinical trials for multiple cancers beyond bladder.

Claim: ImmunityBio's drug N-803 (anktiva) is being investigated or has demonstrated efficacy in treating, curing, or preventing cancer types beyond bladder cancer. NOT BS